What trends should we look for it we want to identify stocks that can multiply in value over the long term? One ...

These ASX 200 healthcare shares, including Mesoblast Ltd (ASX: MSB) and Resmed Inc CDI (ASX: RMD), were in great health in ...

SFM, ADBE, GE, and RMD stand out as GARP stocks blending solid growth potential with reasonable valuations for smart returns.

Shares of ResMed Inc. RMD rallied 1.11% to $258.00 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.52% to 6,204.95 and the ...

In a report released today, Derek Jellinek from Morgans maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD – Research Report) ...

Let's see what analysts are saying about this blue chip as it nears a 52-week high. The ResMed Inc (ASX: RMD) share price has quietly staged a strong comeback over the past year. After a sharp ...

Farrell sold 8,009 shares of ResMed common stock at a weighted average price of $251.21 per share, totaling approximately $2.01 million. This transaction was conducted under a pre-established Rule ...

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025 SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and ...

KeyBanc Capital Markets maintained its Overweight rating and $274.00 price target on ResMed (NYSE: RMD) stock following industry observations. The target aligns with broader analyst expectations, with ...